Matches in Nanopublications for { ?s ?p "[Our studies suggest that new strategies targeting erbB3 or Survivin may enhance the efficacy of chemotherapeutic agents against erbB2-overexpressing breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP814305.RAEP5I4VuxO9DCaquDFPrhMTEJ_3DNR9W4BqfQJ4jfHbY130_assertion description "[Our studies suggest that new strategies targeting erbB3 or Survivin may enhance the efficacy of chemotherapeutic agents against erbB2-overexpressing breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814305.RAEP5I4VuxO9DCaquDFPrhMTEJ_3DNR9W4BqfQJ4jfHbY130_provenance.
- NP814303.RA_8eokmt0LR0ql4UDr2C1yn7b0kdU6wS7pmxZGCd4oLA130_assertion description "[Our studies suggest that new strategies targeting erbB3 or Survivin may enhance the efficacy of chemotherapeutic agents against erbB2-overexpressing breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814303.RA_8eokmt0LR0ql4UDr2C1yn7b0kdU6wS7pmxZGCd4oLA130_provenance.